Skip to main content

Advertisement

Log in

Regression of Immunoproliferative Small Intestinal Disease After Eradication of Helicobacter pylori

  • Brief Communication
  • Published:
Journal of Gastrointestinal Cancer Aims and scope Submit manuscript

Abstract

A 20-year-old male presented with low-grade fever, abdominal pain, anorexia, and weight loss of 4-month duration. On examination, he was emaciated. Barium meal follow-through examination showed extensive nodularity and thickening of duodenal and jejunal folds. Contrast-enhanced computed tomography of the abdomen revealed extensive proximal small-bowel thickening with mesenteric lymphadenopathy. Upper gastrointestinal endoscopy and enteroscopy revealed thickening of folds with multiple small superficial ulceration involving antrum, duodenum, and jejunum. The duodenal and jejunal biopsy was suggestive of immunoproliferative small intestinal disease, stage 0 (Salem) or stage A (Galian). Antral biopsy showed presence of Helicobacter pylori infection. He underwent H. pylori eradication following which he had significant clinical improvement; repeat evaluation at 6 months showed dramatic improvement in his clinical, radiological, and histological parameters.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

References

  1. Wotherspoon AC, Doglioni C, Diss TC, et al. Regression of primary low grade B-cell gastric lymphoma of mucosa associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet. 1993;342:575–7.

    Article  CAS  PubMed  Google Scholar 

  2. Martin IG, Aldoori MI. Immunoproliferative small intestinal disease: Mediterranean lymphoma and α heavy chain disease. Br J Surg. 1994;81:20–4.

    Article  CAS  PubMed  Google Scholar 

  3. Bull D. Alpha-chain disease and related small intestinal lymphoma: a memorandum. Bull World Health Organ. 1976;54:615–24.

    Google Scholar 

  4. Rambaud JC, Halphen M, Galian A, Tsapis A. Immunoproliferative small intestinal disease (IPSID): relationships with alpha-chain disease and “Mediterranean” lymphomas. Springer Semin Immunopathol. 1990;12:239–50.

    Article  CAS  PubMed  Google Scholar 

  5. Khojasteh A, Haghighi P. Immunoproliferative small intestinal disease: portrait of a potentially preventable cancer from the Third World. Am J Med. 1990;89:483–90.

    Article  CAS  PubMed  Google Scholar 

  6. Khojasten A. Immunopathology of the small intestine. In: Marsh MN, editor. Chichester. United Kingdom: Wiley; 1987. p. 121–50.

    Google Scholar 

  7. Fine KD, Stone MJ. Alpha-heavy chain disease, Mediterranean lymphoma, and immunoproliferative small intestinal disease: a review of clinicopathological features, pathogenesis, and differential diagnosis. Am J Gastroenterol. 1999;94:1139–52.

    CAS  PubMed  Google Scholar 

  8. Jaffe ES, Harris NL, Stein H, Vardiman JW. Tumors of hematopoietic and lymphoid tissue. Lyon: IARC; 2001.

    Google Scholar 

  9. Al-Saleem T, Al-Mondhiry H. Immunoproliferative small intestinal disease (IPSID): a model for mature B-cell neoplasms. Blood. 2005;105:2274–80.

    Article  CAS  PubMed  Google Scholar 

  10. Santhi Swaroop V, Advani SH, Damle SR, et al. Spectrum of alpha chain disease in India. Indian J Cancer. 1983;20:261–7.

    Google Scholar 

  11. Akbulut H, Soykan I, Yakaryilmaz F, et al. Five year results of the treatment of 23 patients with immunoproliferative small intestinal disease: a Turkish experience. Cancer. 1997;80:8–14.

    Article  CAS  PubMed  Google Scholar 

  12. Nikbin B, Banisadre M, Ala F, Kijtabai A. HLA AW 19, B12 in immunoproliferative small intestinal disease. Gut. 1979;20:226–8.

    Article  CAS  PubMed  Google Scholar 

  13. Crabbé PA, Nash DR, Bazin H, Eyssen H, Heremans JF. Immunohistochemical observations on lymphoid tissues from conventional and germ free mice. Lab Invest. 1970;22:448–57.

    PubMed  Google Scholar 

  14. Bayerdorffer E, Neubauer A, Rudolph B, et al. Regression of primary gastric lymphoma of mucosa associated lymphoid tissue type after cure of Helicobacter pylori infection. Lancet. 1995;345:1591–4.

    Article  CAS  PubMed  Google Scholar 

  15. Alkan S, Karcher DS, Newman MA, Cohen P. Regression of salivary gland MALT lymphoma after treatment Helicobacter pylori. Lancet. 1996;348:268–9.

    Article  CAS  PubMed  Google Scholar 

  16. Fischback W, Tacke W, Greiner HK, Hermelink M. Regression of immunoproliferative small intestinal disease after eradication of Helicobacter pylori. Lancet. 1997;349:31–2.

    Article  Google Scholar 

  17. Rambaud JC. Small intestinal lymphomas and alpha-chain disease. Clin Gastroenterol. 1983;12:743–6.

    CAS  PubMed  Google Scholar 

  18. Malekzadek OR, Kaviani MJ, Tabei SZ, Abdolhadi B, Haghshenas M, Navab F. Lack of association between Helicobacter pylori infection and immunoproliferative small intestinal disease. http://www.sums.ac.ir/aim/9812/malekzadeh9812.html.

Download references

Conflict of interest

Authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Usha Dutta.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dutta, U., Udawat, H., Noor, M.T. et al. Regression of Immunoproliferative Small Intestinal Disease After Eradication of Helicobacter pylori . J Gastrointest Canc 41, 212–215 (2010). https://doi.org/10.1007/s12029-010-9138-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12029-010-9138-z

Keywords

Navigation